PANGENETICS

PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated diseases. PanGenetics is a clinical development company that specializes in taking antibodies from the late research stage through to clinical proof of concept. The company is based in Utrecht, the Netherlands with an office in Cambridge, UK. PanGenetics employs a lean business model with manufacturing and clinical development activities outsourced to specialist providers. Apart from PG110, the other clinical program of PanGenetics is PG102, a CD40 antagonist for treatment of autoimmune diseases which is currently being evaluated in a clinical study in psoriatic arthritis patients

#People #Financial #Website #More

PANGENETICS

Social Links:

Industry:

Pharmaceutical

Founded:

1995-01-01

Address:

Utrecht, Utrecht, The Netherlands

Country:

The Netherlands

Website Url:

http://www.pangenetics.com

Total Employee:

11+

Status:

Active

Contact:

+31302537911

Total Funding:

52.71 M USD

Technology used in webpage:

Amazon Amazon Ohio Region

Current Employees Featured

kevin-johnson_image

Kevin Johnson
Kevin Johnson CEO @ PanGenetics
CEO

Investors List

forbion-capital-partners_image

Official Site Inspections

http://www.pangenetics.com

Host Informations
Whois Informations

Loading ...